CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report)’s stock price rose 4.4% during trading on Thursday . The stock traded as high as C$3.79 and last traded at C$3.79. Approximately 833 shares changed hands during trading, a decline of 79% from the average daily volume of 3,955 shares. The stock had previously closed at C$3.63.
CSPC Pharmaceutical Group Trading Up 3.7%
The firm’s fifty day moving average is C$4.42 and its 200 day moving average is C$4.47.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Recommended Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
